A clinical stage company with facilities and operations in San Diego, CA and in Omaha, NE, SignalRx Pharmaceuticals is structured around development effective anti=cancer treatments inducing the immune system to attack cancer while blocking the most important and critical cell signaling pathways that cancer cells use to proliferate, migrate, metastasize, and recruit a blood supply. Efforts of the principals are aimed at combining the maximum anticancer activity into the firm's drugs by selectively inhibiting as many important cancer targets as possible in a well-tolerated non-toxic manner where the immune system machinery of the patient is engaged to achieve maximum synergistic anticancer effects.
